Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

pharma business models

This page shows the latest pharma business models news and features for those working in and with pharma, biotech and healthcare.

Gradually, then suddenly

Gradually, then suddenly

My research on how our changing industry environment is driving the evolution of pharma and medtech business models always seems to create enough cognitive dissonance in the group to break the ... models become ‘unfit’, in the evolutionary sense of

Latest news

  • A butterfly flaps its wings A butterfly flaps its wings

    And, like all environmental changes, it will create opportunities and threats for existing business models. ... This creates an opportunity for pharma and medtech business models for whom affluent consumers are the primary target market; these need not

  • Managing pharma's uncertainty Managing pharma's uncertainty

    Response to external forces by reactive adaptation in proportion to impact on current business. ... Shaping of controllable external forces by early, proactive engagement in proportion to impact on future business.

  • Pharma investment in marketing flat in 2013 Pharma investment in marketing flat in 2013

    In a sign of pharma's changing business models, new data has demonstrated that the industry's investment in sales force and marketing channels was flat at just under 85bn for ... In the last six months of 2013, all digital channels tracked by CSD,

  • Sex is a good trick Sex is a good trick

    Market access is a co-evolutionary problem. Payer systems and industry business models are tied together in a co-evolutionary process in which change in one is both restricted and encouraged ... But what do we observe when pharma companies try to develop

  • Hollow victory: the dangers of success Hollow victory: the dangers of success

    In our research about how pharma companies are adapting to a changing market, the capacity of firms to change is obviously an important factor. ... Even the most successful pharma companies risk being overtaken by their less successful followers .

More from news
Approximately 1 fully matching, plus 16 partially matching documents found.

Latest Intelligence

  • Creating value from value-based healthcare Creating value from value-based healthcare

    Why pharma companies need to implement novel business models and more. ... The companies that are able to identify the systems and stakeholders willing to pay for both outcomes and savings on total costs will be able to implement novel business models,.

  • Lonely planet: why there is dwindling value in pharma travelling alone Lonely planet: why there is dwindling value in pharma travelling alone

    To develop sustainable business models that establish value ‘beyond the pill’, collaboration is the best way forward. ... Published in 2009, Pharma 2020: Challenging Business Models argued that pharma would need to collaborate with academic

  • Managing medication non-adherence Managing medication non-adherence

    In this era of value-based payment models becoming mainstream, this is certainly a triple whammy of benefits for all pharma companies to aim for. ... When the business models are sufficiently attractive for the pharma companies to take notice, narrowband

  • Healthcare business and operating models redefined Healthcare business and operating models redefined

    They must realise the fundamental impact new business models will have on their organisations. ... Emerging business models  . Meanwhile, new business models which incorporate fundamentally different economics are solidifying.

  • Digital Business Models Digital Business Models

    But life sciences companies must design and build entirely new business models that embrace digital. ... They must take a fresh look at their capabilities and business models and find entirely new ways to meet the needs of consumers.

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

  • Mueller Hale Consulting

    We generate Pharma Business Case Models to evaluate commercial opportunities and execute strategies as project and interim managers.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Happy Chinese New Year 2020 - The Year of The Rat
A fond farewell to The Year of the Pig...
White Paper for download - Explaining the price of your product
In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...

Quick links

Infographics

Multimedia